GLP1R and type 2 diabetes mellitus: Multiple drugs used in the treatment of T2DM such as sodium‐glucose cotransporter 2 (SGLT)‐inhibitors and glucagon‐like peptide 1 (GLP1) receptor agonists may have a beneficial effect on MASLD/MASH, while other drugs may have a negative effect due to increase in body weight like sulfonylurea derivatives (SU) and insulin.17